Acquired Immune Thrombotic Thrombocytopenic Purpura Following Transaxillary Transcatheter Aortic Valve Replacement: A Rare Life-Threatening Hematologic Emergency. (PubMed, Cureus) - Sep 17, 2026 - "Treatment with plasma exchange, corticosteroids, caplacizumab, and rituximab led to rapid platelet recovery. The diagnosis of iTTP should be considered in patients presenting with unexplained thrombocytopenia and hemolysis after TAVR, even when asymptomatic. Early recognition and prompt initiation of therapy are essential to improve outcomes."
Journal • Cardiovascular • Heart Failure • Hematological Disorders • Thrombocytopenia • Thrombocytopenic Purpura
|
|
Alexandre Tourmous; Anthony Dionso Diyabanza; Joelle Kefer; Nicolas Mubiayi Mujani
|